Gara Jalqabaatti › Dermatitis Atopic (Eczema) › Texas › San Antonio
Qorannoo klinikaalii Dermatitis Atopic (Eczema) San Antonio, TX keessatti
Qorannoo 10 Dermatitis Atopic (Eczema) f San Antonio fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
- Clinical Site 104, San Antonio
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 2
- Novartis Investigative Site, San Antonio
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 2
- Enveda Investigative Site, San Antonio
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
- Texas Dermatology and Laser Specialists, San Antonio
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
Namoota walitti qabaa jiraSadarkaa 3
- Texas Dermatology and Laser Specialists, San Antonio
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 2
- Investigational Site, San Antonio
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 2
- Progressive Clinical Research, PA, San Antonio
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 2
- Enveda Investigative Site, San Antonio
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 3
- Texas Dermatology and Laser Specialists /ID# 267249, San Antonio
- Progressive Clinical Research - San Antonio /ID# 267262, San Antonio
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Namoota walitti qabaa jiraSadarkaa 2
- DCT-Stone Oak, LLC dba Discovery Clinical Trials, San Antonio
Qorannoo Dermatitis Atopic (Eczema) magaalota biroo keessatti
- New York City, NYQorannoo 13
- Los Angeles, CAQorannoo 11
- Washington, DCQorannoo 11
- San Diego, CAQorannoo 10
- Miami, FLQorannoo 9
- Birmingham, ALQorannoo 9
- Troy, MIQorannoo 8
- Dallas, TXQorannoo 8
- Huntington Beach, CAQorannoo 8
- Sacramento, CAQorannoo 8
- Tampa, FLQorannoo 7
- Indianapolis, INQorannoo 7
Qorannoo biroo San Antonio keessatti
- Kansara Qara'a Non-Small CellQorannoo 59
- Kansarii ColorectalQorannoo 46
- Saree OljooQorannoo 46
- Kansara MetastatikiiQorannoo 44
- Saree (Gosoota Hunda)Qorannoo 41
- ObesityQorannoo 40
- Sukkaraa Gosa 2Qorannoo 37
- Baayyee UlfaataaQorannoo 34
- Kansarii OvariiQorannoo 31
- Kansarii PancreasQorannoo 31
- Kansarii ProstateQorannoo 28
- Kansa EndometiriyaaliiQorannoo 27
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.